Processing

Please wait...

Settings

Settings

Goto Application

1. WO2011028847 - POLYVALENT POLYNUCLEOTIDE NANOPARTICLE CONJUGATES AS DELIVERY VEHICLES FOR A CHEMOTHERAPEUTIC AGENT

Publication Number WO/2011/028847
Publication Date 10.03.2011
International Application No. PCT/US2010/047591
International Filing Date 01.09.2010
IPC
A61K 48/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
A61K 9/14 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
CPC
A61K 47/6923
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
69the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
6921the form being a particulate, a powder, an adsorbate, a bead or a sphere
6923the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
B82Y 5/00
BPERFORMING OPERATIONS; TRANSPORTING
82NANOTECHNOLOGY
YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
5Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applicants
  • NORTHWESTERN UNIVERSITY [US]/[US] (AllExceptUS)
  • MASSACHUSETTS INSTITUTE OF TECHNOLOGY [US]/[US] (AllExceptUS)
  • MIRKIN, Chad, A. [US]/[US] (UsOnly)
  • GILJOHANN, David, A. [US]/[US] (UsOnly)
  • DANIEL, Weston, L. [US]/[US] (UsOnly)
  • LIPPARD, Stephen, J. [US]/[US] (UsOnly)
  • DHAR, Shanta [US]/[US] (UsOnly)
Inventors
  • MIRKIN, Chad, A.
  • GILJOHANN, David, A.
  • DANIEL, Weston, L.
  • LIPPARD, Stephen, J.
  • DHAR, Shanta
Agents
  • ALLIKIAN, Michael, J.
Priority Data
61/238,93001.09.2009US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) POLYVALENT POLYNUCLEOTIDE NANOPARTICLE CONJUGATES AS DELIVERY VEHICLES FOR A CHEMOTHERAPEUTIC AGENT
(FR) CONJUGUÉS DE NANOPARTICULE DE POLYNUCLÉOTIDE POLYVALENTE EN TANT QUE VÉHICULES DE DISTRIBUTION POUR UN AGENT CHIMIOTHÉRAPIQUE
Abstract
(EN)
The present invention is directed to compositions and methods of delivering a chemotherapeutic agent via a polynueleotide-functionalized nanoparticle (PN-NP).
(FR)
La présente invention concerne des compositions et des procédés de distribution d'un agent chimiothérapique par l'intermédiaire d'une nanoparticule fonctionnalisée par polynucléotide (PN-NP).
Also published as
Latest bibliographic data on file with the International Bureau